News
Staph bloodstream infection algorithm shortens treatment course
- Author:
- Ted Bosworth
SAN DIEGO - Average antibiotic duration was shortened by almost 2 days.
News
CDC data show decline in some hospital-acquired infections
- Author:
- Ted Bosworth
SAN DIEGO - Reduced use of urinary catheters and central lines appears to be having an effect in controlling some HAIs.
News
Rio Olympics tally for U.S. athletes is 6% West Nile infections, no Zika
- Author:
- Ted Bosworth
SAN DIEGO - A comparison of risk prevention behaviors in those who were and were not infected suggested that use of mosquito repellent did provide...
News
Involving experts in S. aureus bacteremia treatment reduces mortality
- Author:
- Ted Bosworth
SAN DIEGO – Either involvement of an antimicrobial stewardship team or an infectious disease consultant will do.
News
Iceland is making progress toward total eradication of HCV
- Author:
- Ted Bosworth
“If we only scaled up treatment, we would not reach the goal of eliminating HCV infection. We needed something else,”
News
Inappropriate C. diff. testing reduced with ‘Hard Stop’ protocol
- Author:
- Ted Bosworth
A new testing protocol cut <i>C. difficile-infection</i> testing by 42% without delaying any diagnoses.
News
Dentist-prescribed antibiotics implicated in community-acquired C. diff
- Author:
- Ted Bosworth
SAN DIEGO – Dental antibiotics help drive community-acquired C. difficile infections.
News
In the reemergence of typhus, the challenge is early diagnosis
- Author:
- Ted Bosworth
SAN DIEGO – Doxycycline is the drug of choice for almost all of the rickettsial infections.
News
Flotetuzumab for AML passes phase 1 test
- Author:
- Ted Bosworth
Flotetuzumab, a novel bispecific monoclonal antibody that employs a proprietary technology to redirect T lymphocytes to kill CD123-expressing...
News
New antibodies, drugs for refractory and relapsed myeloma are effective in patients over 65
- Author:
- Ted Bosworth
MADRID – Patients with refractory/relapsed multiple myeloma had similar rates of progression-free survival whether they were younger than age 65...
News
AML risk is doubled in low-risk thyroid cancer patients unnecessarily given radioactive iodine therapy
- Author:
- Ted Bosworth
MADRID - Unnecessary radioactive iodine treatment is associated with nearly twice the risk of developing acute myeloid leukemia (AML) in patients...
News
Most daratumumab infusion reactions occur in first infusion
- Author:
- Ted Bosworth
The high rate of infusion-related reactions at first daratumumab infusion may be related to treatment duration, based on data from the CASTOR and...
News
Biosimilar matches rituximab in large follicular lymphoma trial
- Author:
- Ted Bosworth
MADRID – The biosimilar GP2013 met the criteria for therapeutic equivalence to rituximab in a large comparator trial of previously untreated...
News
Alternating therapy in renal cell carcinoma fails to show an advantage
- Author:
- Ted Bosworth
Everolimus alternating with pazopanib and pazopanib alone were compared in a randomized, multicenter controlled trial.
Video
Genetic advances push personalization of cancer prevention
- Author:
- Ted Bosworth
BOSTON – Personalized medicine is expanding to take on the challenges of colorectal cancer prevention.